Atlas Trials

Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid Tumors

Clinical trial NCT03684785 · TERMINATED

Trial details

NCT number
NCT03684785
Sponsor
Exicure, Inc.
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced or Metastatic Merkel Cell CarcinomaAdvanced or Metastatic Cutaneous Squamous Cell CarcinomaAdvanced or Metastatic MelanomaAdvanced or Metastatic Head and Neck Squamous Cell CarcinomaAdvanced or Metastatic Solid Tumors
Start date
2018-12-13
Primary completion
2022-03-30
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.